Harvest Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-128
Closed -$2K – 745
2024
Q1
$2K Hold
128
– – ﹤0.01% 630
2023
Q4
$3K Hold
128
– – ﹤0.01% 591
2023
Q3
$2K Hold
128
– – ﹤0.01% 600
2023
Q2
$3K Sell
128
-841
-87% -$21.2K ﹤0.01% 626
2023
Q1
$25K Sell
969
-1,882
-66% -$50.4K 0.01% 557
2022
Q4
$67K Buy
+2,851
New +$76.9K 0.02% 425
2021
Q2
– Sell
-180
Closed -$31K – 836
2021
Q1
$31K Sell
180
-380
-68% -$88.1K ﹤0.01% 548
2020
Q4
$111K Sell
560
-388
-41% -$78.9K 0.01% 235
2020
Q3
$213K Buy
948
+551
+139% +$117K 0.02% 147
2020
Q2
$78K Sell
397
-1,314
-77% -$230K 0.01% 274
2020
Q1
$265K Buy
+1,711
New +$199K 0.03% 103
2018
Q4
– Sell
-1,914
Closed -$165K – 447
2018
Q3
$165K Buy
+1,914
New +$136K 0.03% 198

Other funds holding TDOC

Harvest Fund Management's TDOC Position: Q2 2024 in Review

Harvest Fund Management sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 128 shares — an estimated $2K sold.

Harvest Fund Management first reported a position in TDOC in Q3 2018 and held it in 12 quarters. The position peaked at $265K in Q1 2020. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Harvest Fund Management reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Harvest Fund Management sold 128 Teladoc Health shares in Q2 2024, an estimated $2K.
  • Harvest Fund Management first reported a position in Teladoc Health in Q3 2018 and held it in 12 quarters.
  • Harvest Fund Management's Teladoc Health position peaked at $265K in Q1 2020.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Harvest Fund Management's 13F filing for Q2 2024, filed 8 Aug 2024.